Orbifloxacin impurity 14 CAS CATO-C4X-256714
| CAS No. | CATO-C4X-256714 |
| Molecular Formula | C17H12BF4NO7 |
| Molecular Weight | 429.08 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
The occurrence of Orbifloxacin impurity 14 is closely related to a flavonoid core, an amide group, a hydroxyl group, an ether linkage, fluorine substitution in its molecular formula, which determines its behaviour during synthesis, purification, or degradation.
CATO supplies Orbifloxacin impurity 14 (CAS CATO-C4X-256714), a pharmacopoeial impurity reference standard (molecular formula C17H12BF4NO7, MW 429.08 g/mol) used for the identification and quantification of trace impurities in APIs.
Orbifloxacin impurity 14 (C17H12BF4NO7) contains a flavonoid core, an amide group, a hydroxyl group, an ether linkage, fluorine substitution. Halogen substitution raises its density and boiling point, the carboxyl group imparts weak acidity; these physicochemical properties determine the optimal preparation and storage of its standard solutions. The presence of an aromatic ring or conjugated system gives the compound characteristic absorption bands in the UV-Vis region, making it well suited to UV or diode-array detection (DAD).
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
CATO manufactures Orbifloxacin impurity 14 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C17H12BF4NO7 |
| Molecular Weight | 429.08 g/mol |
| Appearance | Pale yellow to yellow crystalline powder. (slight halide-like odor, low volatility) |
| Purity | 97%+ |
| Storage | Store at room temperature, protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in methanol, acetonitrile, DMSO, water (slightly soluble) |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 10.5 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| Halogen Content | F-containing |
| Nitrogen Atoms | 1 |
Related Orbifloxacin Standards
- Orbifloxacin-d4 (CAS CATO-CCAD303465)
- Orbifloxacin EP Impurity E (CAS CATO-C4X-25679)
- Orbifloxacin (CAS 113617-63-3)
- Orbifloxacin EP Impurity D (CAS 126458-22-8)
- Orbifloxacin EP Impurity C (CAS 126457-99-6)
- Orbifloxacin EP Impurity A (CAS CATO-C4X-25672)
- Orbifloxacin EP Impurity G (CAS CATO-C4X-25676)
- Orbifloxacin impurity 11 (CAS CATO-C4X-256711)
Recommended Standards
- Pentafluorophenyl 4-amino-3-iodobenzoate (CAS 1086375-59-8)
- Lamotrigine EP Impurity F (CAS 252186-79-1)
- 4-Bromo-3,3,4,4-tetrafluorobutyl (4,4,5,5,5-pentafluoropentyl) carbonate (CAS 1923267-08-6)
- 5,6-Dibromo-2-(4-hydroxy-2-methylphenyl)hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione (CAS 1217674-07-1)
- Mosapride Impurity 64 (CAS CATO-C4X-104464)
- Foritinib Impurity 1 (CAS CATO-C4X-33101)
- Rupatadine Impurity 34 (CAS 2724877-90-9)
- 1-(Prop-1-en-2-yl)cyclobutan-1-ol (CAS 40791-88-6)
- 5,6-Difluoropyrazine-2,3-dicarbonitrile (CAS 887404-02-6)
- 3-Propylpyridine (CAS 4673-31-8)
- 1-Chloro-2-fluoro-3-isopropoxybenzene (CAS 1369791-02-5)
- (4-Bromo-2-fluorophenyl)(3-(morpholinomethyl)phenyl)methanone (CAS 898792-04-6)
- (1-Methyl-5-nitro-1H-imidazol-4-yl)methanol (CAS 85012-70-0)
- Hexapeptide-1 (CAS CATO-CPTD788821)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com